PE Anti-TMEM119 antibody [106-6] - Microglial marker
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Anti-TMEM119 antibody [106-6] - PE conjugated (ab225496) is a rabbit recombinant monoclonal antibody detecting TMEM119 in Flow Cytometry (Intra), Flow Cytometry. Suitable for Human.
- Biophysical QC for unrivalled batch-batch consistency
View Alternative Names
Transmembrane protein 119, Osteoblast induction factor, OBIF, Tmem119
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - PE Anti-TMEM119 antibody [106-6] - Microglial marker (AB225496)
Flow cytometry analysis of HEK-293T (human embryonic kidney) transfected with Myc-His tagged TMEM119 expression vector labelling TMEM119 with ab225496 at 1/500 dilution (right) compared with Rabbit IgG (monoclonal) Phycoerythrin ab209478 (left). Cells were surface-stained with ab225496, then fixed with 2% PFA for 10 minutes and permeabilised with 0.1% Tween-20 for 30 minutes. Next, they were stained with Alexa Fluor® 647 conjugated Myc-tag antibody. Only Myc-tag (+) population showed TMEM119 positive staining.
Related conjugates and formulations (4)
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-TMEM119 antibody [106-6] - Microglial marker
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-TMEM119 antibody [106-6] - Microglial marker
-
Anti-TMEM119 antibody [106-6] - Microglial marker
-
Anti-TMEM119 antibody [106-6] - Microglial marker - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
PE Anti-TMEM119 antibody [106-6] (ab225496) is a rabbit recombinant monoclonal antibody and is validated for use in Flow Cytometry (Intra), Flow Cytometry (Flow Cyt) in Human samples.
Related products
Antibody clone 106-6 is also available pre-conjugated to a variety of labels for your convenience – Anti-TMEM119 PE [106-6] (ab225496).
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TMEM119 regulates signaling pathways that maintain microglial identity and function but does not typically form part of larger complexes. It modulates microglial activation states and influences responses to central nervous system injury and inflammation. As a membrane protein it may interact with other surface molecules although specific binding partners are not well-characterized in current literature. Researchers value TMEM119 as a reliable marker in studies aiming to distinguish brain-resident microglia from infiltrating peripheral macrophages.
Pathways
TMEM119 functions as a modulator within inflammatory and neuroimmune pathways. It plays roles in the NF-kB signaling and the neuroinflammatory cascade. Its relationship with proteins like CD68 and Iba1 indicates it may influence pathways tied to immune responses and phagocytosis within nervous system contexts. Understanding the interactions and co-expression of TMEM119 with these proteins helps clarify its contribution to neuroimmune functions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Cell reports 44:115176 PubMed39842435
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of experimental medicine 221: PubMed38226975
2024
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 19:e0296280 PubMed38180982
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com